Generali Asset Management SPA SGR Cuts Stake in AMETEK, Inc. $AME

Key Points

• Generali Asset Management SPA SGR has reduced its stake in AMETEK, Inc. by 25.1% during the second quarter, now holding 17,734 shares valued at approximately $3.2 million.
• AMETEK recently reported a quarterly earnings per share (EPS) of $1.78, surpassing analysts' expectations, with a revenue of $1.78 billion, marking a 2.5% year-over-year increase.
• The company has announced a quarterly dividend of $0.31 per share, representing an annualized dividend yield of 0.7%, with a payout ratio of 19.97%.

Generali Asset Management SPA SGR reduced its stake in shares of AMETEK, Inc. (NYSE:AME - Free Report) by 25.1% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 17,734 shares of the technology company's stock after selling 5,932 shares during the quarter. Generali Asset Management SPA SGR's holdings in AMETEK were worth $3,209,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also added to or reduced their stakes in AME. Bares Capital Management Inc. purchased a new position in shares of AMETEK in the first quarter valued at $26,000. ST Germain D J Co. Inc. grew its holdings in shares of AMETEK by 628.6% in the second quarter. ST Germain D J Co. Inc. now owns 153 shares of the technology company's stock valued at $28,000 after purchasing an additional 132 shares in the last quarter. Olde Wealth Management LLC purchased a new position in shares of AMETEK in the first quarter valued at $29,000. Annis Gardner Whiting Capital Advisors LLC grew its holdings in shares of AMETEK by 57.7% in the first quarter. Annis Gardner Whiting Capital Advisors LLC now owns 194 shares of the technology company's stock valued at $33,000 after purchasing an additional 71 shares in the last quarter. Finally, Zions Bancorporation National Association UT purchased a new position in shares of AMETEK in the first quarter valued at $42,000. 87.43% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on the stock. Mizuho raised their target price on shares of AMETEK from $212.00 to $225.00 and gave the company an "outperform" rating in a report on Friday, August 1st. Melius lowered shares of AMETEK from a "buy" rating to a "hold" rating and set a $192.00 target price for the company. in a report on Monday, July 14th. DA Davidson lifted their price objective on shares of AMETEK from $210.00 to $215.00 and gave the stock a "buy" rating in a research note on Friday, August 1st. Melius Research raised shares of AMETEK to a "hold" rating in a research note on Monday, July 14th. Finally, TD Cowen raised shares of AMETEK from a "sell" rating to a "hold" rating and lifted their price objective for the stock from $158.00 to $180.00 in a research note on Tuesday, September 2nd. Eight equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average price target of $207.42.

AMETEK Stock Down 0.7%

NYSE:AME opened at $184.44 on Friday. The company has a market cap of $42.60 billion, a price-to-earnings ratio of 29.70, a price-to-earnings-growth ratio of 2.67 and a beta of 1.11. AMETEK, Inc. has a twelve month low of $145.02 and a twelve month high of $198.33. The company has a current ratio of 1.63, a quick ratio of 1.04 and a debt-to-equity ratio of 0.15. The stock has a fifty day simple moving average of $185.61 and a 200-day simple moving average of $178.21.

AMETEK (NYSE:AME - Get Free Report) last issued its earnings results on Thursday, July 31st. The technology company reported $1.78 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.69 by $0.09. The firm had revenue of $1.78 billion during the quarter, compared to analyst estimates of $1.74 billion. AMETEK had a net margin of 20.60% and a return on equity of 16.53%. The business's revenue was up 2.5% on a year-over-year basis. During the same period in the previous year, the firm earned $1.66 earnings per share. AMETEK has set its Q3 2025 guidance at 1.720-1.760 EPS. FY 2025 guidance at 7.060-7.200 EPS. Analysts anticipate that AMETEK, Inc. will post 7.15 EPS for the current year.

AMETEK Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 30th. Stockholders of record on Monday, September 15th were paid a dividend of $0.31 per share. This represents a $1.24 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend was Monday, September 15th. AMETEK's payout ratio is currently 19.97%.

AMETEK Company Profile

AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices in the North America, Europe, Asia, and South America, and internationally. The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets; power quality monitoring and c devices, uninterruptible power supplies, programmable power and electromagnetic compatibility test equipment, and sensors for gas turbines and dashboard instruments; heavy trucks, instrumentation, and controls for the food and beverage industries; and aircraft and engine sensors, power supplies, embedded computing, monitoring, fuel and fluid measurement, and data acquisition systems for aerospace and defense industry.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.